does semaglutide damage kidneys Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria Wegovy and Kidney Stones: Risk,

The documented failure modes in the compounded GLP-1 category are specific, sourced, and preventable with the right questions asked before enrollment rather than after

These are minor complaints relative to the overall satisfaction, but worth noting for transparency

Implications for providers and patients The demand for weight loss drugs is not slowing down, and many organizations voiced concerns that there will likely be semaglutide shortages in the future that will impact patients' access to branded medications

Mller, T

It does mean that buyers who start a compounded GLP-1 program in mid-2026 should be aware of how quickly the regulatory picture may shift, and should discuss continuity of care planning with their assigned clinical provider before committing to a multi-month program